Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Is This a Setback for Moderna?
06:35am, Tuesday, 14'th May 2024
Moderna's waiting for the FDA to give it a nod for its next potential blockbuster -- an RSV vaccine. But the FDA is taking longer than planned to review the vaccine candidate.
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
12:26pm, Monday, 13'th May 2024
Moderna's (MRNA) RSV vaccine, mRNA-1345's review timeline gets delayed. A decision is now expected by the end of May.
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
10:02am, Monday, 13'th May 2024
Moderna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
08:45am, Monday, 13'th May 2024
Moderna has a deep pipeline that should help it land brand-new approvals regularly. DexCom has a massive opportunity in the vast continuous glucose monitoring market.
Moderna to Present at Upcoming Conferences in May/June 2024
07:00am, Monday, 13'th May 2024
CAMBRIDGE, MA / ACCESSWIRE / May 13, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: Bernstein's 40th Annual Strategic Decisions C
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
09:25am, Sunday, 12'th May 2024
Moderna is using OpenAI's ChatGPT and other tools extensively. In particular, OpenAI's solution is helping with some much-dreaded work.
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
12:45pm, Friday, 10'th May 2024
Moderna (MRNA) shares lost ground in intraday trading Friday as the biotech's effort to move beyond just a COVID-19 vaccine was stalled somewhat by U.S. regulators looking at its new shot to treat res
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
07:45am, Friday, 10'th May 2024
Moderna Inc.'s stock fell 1.8% early Friday, after the company said the Food and Drug Administration will not complete its review of the company's respiratory syncytial virus, or RSV, vaccine by the o
Will the Biotech Sector Shift From Lagger to Leader?
07:24am, Friday, 10'th May 2024
The biotech sector and its popular ETF, the iShares Biotechnology ETF NASDAQ: IBB, have lagged the overall market during the year, with its shares slightly red. However, in recent weeks, the sector ha
US FDA pushes decision on Moderna's RSV vaccine to end of this month
07:07am, Friday, 10'th May 2024
The U.S. Food and Drug Administration has pushed back its decision on Moderna's respiratory syncytial virus (RSV) vaccine by more than two weeks to the end of this month due to some "administrative co
Moderna says FDA delayed RSV vaccine approval to end of May
07:00am, Friday, 10'th May 2024
The FDA has not informed Moderna of any issues related to the vaccine's safety, efficacy or quality that would prevent its approval, the biotech company said.
Moderna Announces Update on Investigational RSV Vaccine
07:00am, Friday, 10'th May 2024
U.S. FDA has informed Moderna that due to administrative constraints, the agency will not complete its review of mRNA-1345 by the PDUFA date of May 12, 2024 Agency has indicated it expects to complete
Moderna's Promise of mRNA Undercut by New RSV Vaccine
11:35am, Thursday, 09'th May 2024
Moderna's second vaccine, meant to prevent a common respiratory virus, is calling into question the premise on which the company has staked its entire business. Gerry Smith reports on Bloomberg Televi
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
09:05am, Thursday, 09'th May 2024
Prior to the COVID pandemic, the biopharma outfit wasn't a particularly well-known name. Being one of the few pharma companies that could quickly come up with a vaccine, however, catapulted its stock.
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
12:02pm, Wednesday, 08'th May 2024
Moderna stock broke out of a cup-with-handle base after its first-quarter sales and earnings report. Is MRNA stock a buy right now?
